NYSE: PSX

Phillips 66

CIK 0001534701 · SIC 2911 · Petroleum Refining

Mega Revenue $132.4B Assets $86.0B as of Nov 15, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (JEF 10-Q) is open in full — no account needed.

8-K Filed Oct 28, 2026 · Period ending Oct 28, 2026

Summary not yet generated.

10-Q Filed Oct 28, 2026 · Period ending Sep 30, 2026

Summary not yet generated.

Partner

Trade PSX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Oct 5, 2026 · Period ending Sep 29, 2026

Summary not yet generated.

8-K Filed Aug 21, 2026 · Period ending Aug 20, 2026

Phillips 66 expands receivables securitization to $2B, extends maturity to Aug 2027

3 material changes detected. Sign up free to read the summary.

10-Q Filed Aug 5, 2026 · Period ending Jun 30, 2026

Phillips 66 Q2 2026 net income surges 339% to $3.85B

4 material changes detected. Sign up free to read the summary.

8-K Filed Aug 5, 2026 · Period ending Aug 5, 2026

Summary not yet generated.

8-K Filed May 14, 2026 · Period ending May 13, 2026

Summary not yet generated.

10-Q Filed Apr 29, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K Filed Feb 20, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Oct 29, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

424B3 Filed Sep 16, 2025

Summary not yet generated.

10-Q Filed Jul 28, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-K Filed Feb 21, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

424B3 Filed Sep 9, 2024

Summary not yet generated.

424B3 Filed Feb 26, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Oct 28, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Statement of Income

Millions of Dollars

Description Three months ended September 30 2026 Three months ended September 30 2025 Nine months ended September 30 2026 Nine months ended September 30 2025
Revenues and Other Income
Sales and other operating revenues 50,540 34,515 134,084 98,268
Equity in earnings of affiliates 561 337 1,448 643
Net gain on dispositions 1 11 124 1,005
Other income 404 116 896 311
Total Revenues and Other Income 51,506 34,979 136,552 100,227
Costs and Expenses
Purchased crude oil and products 40,814 30,219 113,694 86,956
Operating expenses 1,867 1,492 5,558 4,554
Selling, general and administrative expenses 625 792 1,700 1,893
Depreciation and amortization 591 826 1,734 2,433
Impairments 32 951 49 981
Taxes other than income taxes 201 221 562 672
Accretion on discounted liabilities 14 12 39 34
Interest and debt expense 243 259 843 744
Foreign currency transaction (gains) losses 11 8 34 (7)
Total Costs and Expenses 44,398 34,780 124,213 98,260
Income before income taxes 7,108 199 12,339 1,967
Income tax expense 1,469 32 2,602 366
Net Income 5,639 167 9,737 1,601
Less: net income attributable to noncontrolling interests 23 34 67 104
Net Income Attributable to Phillips 66 5,616 133 9,670 1,497
Net Income Attributable to Phillips 66 Per Share of Common Stock (dollars)
Basic 14.14 0.32 24.16 3.67
Diluted 14.08 0.32 24.05 3.66
Weighted-Average Common Shares Outstanding (thousands)
Basic 397,011 404,508 399,983 406,801
Diluted 398,953 405,549 402,119 407,885
See Notes to Consolidated Financial Statements.

Consolidated Balance Sheet

Millions of Dollars

Description September 30 2026 December 31 2025
Assets
Cash and cash equivalents 5,848 1,116
Accounts and notes receivable (net of allowances of $72 million in 2026 and $68 million in 2025) 12,477 9,158
Accounts and notes receivable—related parties 754 613
Inventories 6,248 5,097
Prepaid expenses and other current assets 2,594 1,287
Total Current Assets 27,921 17,271
Investments and long-term receivables 12,719 11,905
Net properties, plants and equipment 39,733 39,097
Goodwill 1,433 1,433
Intangibles 968 978
Other assets 3,181 2,996
Total Assets 85,955 73,680
Liabilities
Accounts payable 13,524 8,581
Accounts payable—related parties 597 286
Short-term debt 1,045 1,038
Accrued income and other taxes 2,687 1,362
Employee benefit obligations 739 680
Other accruals 2,183 1,379
Total Current Liabilities 20,775 13,326
Long-term debt 17,485 18,678
Asset retirement obligations and accrued environmental costs 1,081 1,022
Deferred income taxes 7,692 7,308
Employee benefit obligations 484 573
Other liabilities and deferred credits 2,935 2,532
Total Liabilities 50,452 43,439
Equity
Common stock (2,500,000,000 shares authorized at $0.01 par value) Issued (2026—661,901,460 shares; 2025—659,391,484 shares)
Par value 7 7
Capital in excess of par 20,138 19,948
Treasury stock (at cost: 2026—271,829,098 shares; 2025—258,252,603 shares) (26,940) (23,934)
Retained earnings 41,380 33,239
Accumulated other comprehensive loss (254) (167)
Total Stockholders’ Equity 34,331 29,093
Noncontrolling interests 1,172 1,148
Total Equity 35,503 30,241
Total Liabilities and Equity 85,955 73,680

Consolidated Statement of Cash Flows

Millions of Dollars

Description Nine months ended September 30 2026 Nine months ended September 30 2025
Cash Flows From Operating Activities
Net income 9,737 1,601
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization 1,734 2,433
Impairments 49 981
Accretion on discounted liabilities 39 34
Deferred income taxes 375 (167)
Undistributed equity earnings (952) 140
Net gain on dispositions (124) (1,005)
Unrealized investment loss 21 10
Other 322 72
Working capital adjustments
Accounts and notes receivable (3,746) (42)
Inventories (1,190) (2,430)
Prepaid expenses and other current assets (1,309) (534)
Accounts payable 5,269 406
Taxes and other accruals 2,051 711
Net Cash Provided by Operating Activities 12,276 2,210
Cash Flows From Investing Activities
Capital expenditures and investments (1,988) (1,551)
Acquisitions, net of cash acquired (179) (2,210)
Return of investments in equity affiliates 59 58
Proceeds from asset dispositions 87 2,031
Other (9) 42
Net Cash Used in Investing Activities (2,030) (1,630)
Cash Flows From Financing Activities
Issuance of debt 8,190 5,949
Repayments and repurchases of debt (9,275) (3,987)
Issuance of common stock 155 93
Repurchase of common stock (2,921) (933)
Dividends paid on common stock (1,521) (1,440)
Distributions to noncontrolling interests (95) (123)
Contributions from noncontrolling interests 52 124
Other (68) (94)
Net Cash Used in Financing Activities (5,483) (411)
Effect of Exchange Rate Changes on Cash and Cash Equivalents (31) 43
Net Change in Cash and Cash Equivalents, including cash classified within Assets held for sale 4,732 212
Cash and cash equivalents at beginning of period 1,116 1,738
Cash and Cash Equivalents at End of Period, including cash classified within Assets held for sale 5,848 1,950

Amounts as printed on the EDGAR/iXBRL face — Millions of Dollars. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗